GGHCX Mutual Fund

GGHCX Mutual Fund

NAV$41.27
See how much of GGHCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$648M
Expense Ratio
1.07%
Dividend Yield (Current)
-
Holdings
79
Inception Date
Aug 7, 1989
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+12.44%
1 Year+16.38%
3 Year+14.24%
5 Year+3.91%
10 Year+9.28%

Asset Allocation

Stocks: 97.00%
Cash: 1.21%
Other: 1.79%
See how much of GGHCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co10.58%
JNJJohnson & Johnson - Common6.92%
MRKMerck & Company Inc5.08%
UNHUnitedhealth Group Incorporated5.07%
ABBVAbbvie Inc.4.24%
Top 10 Concentration: 46.78%Report Date: Sep 30, 2026
Download all 79 holdings for GGHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$9.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

GGHCX Mutual Fund Overview

GGHCX Mutual Fund (Invesco Health Care Fund Class A) is managed by Invesco (US) with $647.7M in net assets. GGHCX expense ratio is 1.07%, holding 79 positions across sectors including Health Care, Financials, Real Estate. Inception date: 1989-08-07.

GGHCX performance shows a YTD return of 12.44%. The 1-year return is 16.38% and the 5-year return is 3.91%.

GGHCX top holdings include Eli Lilly & Co (10.6%), Johnson & Johnson - Common (6.9%), Merck & Company Inc (5.1%), Unitedhealth Group Incorporated (5.1%), Abbvie Inc. (4.2%). Go to all GGHCX holdings, GGHCX sectors, or GGHCX dividends.

GGHCX can be compared against other funds. Use GGHCX overlap to find shared positions, or GGHCX vs another fund for a side-by-side view. GGHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.